Subsequent construction of a protein-protein interaction (PPI) network, along with GO and KEGG enrichment analyses, highlighted EGFR and JUN as key prognostic targets for predicting five-year survival in glioma patients. This evidence concerns the gene JUN and central nervous system cancer.